[HTML][HTML] Recent advances in zirconium-89 chelator development

NB Bhatt, DN Pandya, TJ Wadas - Molecules, 2018 - mdpi.com
The interest in zirconium-89 (89Zr) as a positron-emitting radionuclide has grown
considerably over the last decade due to its standardized production, long half-life of 78.2 h …

[HTML][HTML] The race for hydroxamate-based zirconium-89 chelators

IVJ Feiner, M Brandt, J Cowell, T Demuth, D Vugts… - Cancers, 2021 - mdpi.com
Simple Summary Chelators are small molecules that can form a complex with a metal ion by
coordinating electron rich atoms from the chelator to the electron-poor cation …

[HTML][HTML] Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET

R Raavé, G Sandker, P Adumeau, CB Jacobsen… - European Journal of …, 2019 - Springer
Purpose Currently, the most commonly used chelator for labelling antibodies with 89 Zr for
immunoPET is desferrioxamine B (DFO). However, preclinical studies have shown that the …

Predicting the thermodynamic stability of zirconium radiotracers

JP Holland - Inorganic chemistry, 2020 - ACS Publications
The thermodynamic stability of a metal–ligand complex, as measured by the formation
constant (log β), is one of the most important parameters that determines metal ion selectivity …

The chemistry of PET imaging with zirconium-89

JR Dilworth, SI Pascu - Chemical Society Reviews, 2018 - pubs.rsc.org
This Tutorial Review aims to provide an overview of the use of zirconium-89 complexes in
biomedical imaging. Over the past decade there have been many new papers in this field …

Zirconium immune-complexes for PET molecular imaging: current status and prospects

L Melendez-Alafort, G Ferro-Flores, L De Nardo… - Coordination Chemistry …, 2023 - Elsevier
Diagnostic molecular images, obtained by positron emission tomography (PET), have
successfully functioned as sensitive tools for detecting and monitoring the treatment of …

Macrocyclic 1, 2-Hydroxypyridinone-based chelators as potential ligands for Thorium-227 and Zirconium-89 radiopharmaceuticals

JJ Woods, AG Cosby, JN Wacker… - Inorganic …, 2023 - ACS Publications
Thorium-227 (227Th) is an α-emitting radionuclide that has shown preclinical and clinical
promise for use in targeted α-therapy (TAT), a type of molecular radiopharmaceutical …

Polyazamacrocycle Ligands Facilitate 89Zr Radiochemistry and Yield 89Zr Complexes with Remarkable Stability

DN Pandya, KE Henry, CS Day, SA Graves… - Inorganic …, 2020 - ACS Publications
Over the last three decades, the chemistry of zirconium has facilitated antibody development
and the clinical management of disease in the precision medicine era. Scientists have …

[HTML][HTML] Click-to-Release: Cleavable Radioimmunoimaging with [89Zr] Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio

M Vlastara, R Rossin, FJM Hoeben, KE de Roode… - Theranostics, 2023 - ncbi.nlm.nih.gov
One of the main challenges of PET imaging with 89 Zr-labeled monoclonal antibodies
(mAbs) remains the long blood circulation of the radiolabeled mAbs, leading to high …

A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89 zirconium for positron emission tomography (PET) imaging

C Buchwalder, C Rodríguez-Rodríguez… - Dalton …, 2017 - pubs.rsc.org
Zirconium-89 (89Zr) is an ideal radiometal isotope for antibody-based positron emission
tomography (immunoPET) as its physical half-life (3.27 days) is a good match with the …